Division of General Medicine and Primary Care, Brigham & Women's Hospital, 1620 Tremont St, Boston, MA 02120, USA.
BMJ Qual Saf. 2012 Nov;21(11):933-8. doi: 10.1136/bmjqs-2012-000946. Epub 2012 Jul 12.
To determine how often serious or life-threatening medication administration errors with the potential to cause harm (potential adverse drug events) result in actual harm (adverse drug events (ADEs)) in the hospital setting.
Retrospective chart review of clinical events following observed medication administration errors.
Medication errors are common at the medication administration stage for inpatients. While many errors can cause harm, it is unclear exactly how often.
In a previous study where 14 041 medication administrations were directly observed, 1271 medication administration errors were discovered, of which 133 had the potential to cause serious or life-threatening harm and were considered serious or life-threatening potential adverse drug events. As a follow-up, clinical reviewers conducted detailed chart review of serious or life-threatening potential ADEs to determine if they caused an ADE. Reviewers assessed severity of the ADE and attribution to the error.
Ten (7.5% (95% CI 6.98 to 8.01)) actual ADEs resulted from the 133 serious and life-threatening potential ADEs, of which 6 resulted in significant, three in serious, and one life threatening injury. Therefore 4 (3% (95% CI 2.12 to 3.6)) of serious or life threatening potential ADEs led to serious or life threatening ADEs. Half of the ADEs were caused by dosage or monitoring errors for anti-hypertensives.
Unintercepted potential ADEs at the medication administration stage can cause serious patient harm. At hospitals where 6 million doses are administered per year, about 4000 preventable ADEs would be attributable to medication administration errors annually.
确定在医院环境中,潜在的严重或危及生命的药物管理错误(潜在的药物不良事件)导致实际伤害(药物不良事件(ADE))的频率。
对观察到的药物管理错误后发生的临床事件进行回顾性图表审查。
在住院患者的药物管理阶段,药物错误很常见。虽然许多错误会造成伤害,但尚不清楚实际发生的频率。
在之前的一项研究中,直接观察了 14041 次药物给药,发现了 1271 次药物给药错误,其中 133 次有造成严重或危及生命的潜在危害,并被认为是严重或危及生命的潜在药物不良事件。作为后续行动,临床审查员对严重或危及生命的潜在 ADE 进行了详细的图表审查,以确定它们是否导致 ADE。审查员评估了 ADE 的严重程度和归因于错误的情况。
在 133 例严重和危及生命的潜在 ADE 中,有 10 例(7.5%(95%CI 6.98 至 8.01))实际发生了 ADE,其中 6 例导致严重伤害,3 例导致严重伤害,1 例导致危及生命的伤害。因此,4(3%(95%CI 2.12 至 3.6))严重或危及生命的潜在 ADE 导致了严重或危及生命的 ADE。一半的 ADE 是由抗高血压药物的剂量或监测错误引起的。
药物管理错误在药物管理阶段未被拦截,可能导致严重的患者伤害。在每年给药 600 万剂的医院中,每年约有 4000 例可预防的 ADE 归因于药物管理错误。